Vaccines,
Journal Year:
2022,
Volume and Issue:
10(10), P. 1736 - 1736
Published: Oct. 17, 2022
Background:
The
waning
vaccine
immunity
and
emergence
of
new
variants
SARS-CoV-2
led
health
authorities
across
the
globe
to
administer
booster
doses
(BDs)
COVID-19
vaccine.
Hence,
current
study
aimed
assess
hesitancy
(VBH)
amongst
Pakistani
healthcare
professionals
(HCPs).
Methods:
A
nationwide
survey-based
was
carried
out
from
April
2022
May
2022.
online
self-administered
questionnaire
utilized
collect
data
regarding
demographics
(age,
gender,
marital
status,
profession,
residential
area,
province),
infection
history
(infection
history,
onset,
clinical
severity
disease),
previous
vaccination
(type
number
doses),
attitudes
towards
BDs
(acceptance,
rejection,
hesitancy),
psychological
drivers
VBH
(perceived
effectiveness,
safety,
risk/benefit
ratio,
type
preference).
We
assessed
association
between
dependent
variable
participants,
independent
variables
(demographics,
vaccination,
VBH),
by
using
Chi-square
test/Fisher
exact
test.
Results:
Among
1164
51.4%
were
male,
80.4%
medical
professionals.
half
participants
(52.1%)
agreed
take
BD
or
had
already
taken
it,
while
rest
them
refused
(34.7%)
hesitated
(24.2%)
it.
These
significantly
associated
(p
<
0.001)
with
divers
about
BD.
Conclusion:
This
revealed
that
HCPs
hesitant
concerns
efficacy,
risk/benefits
ratio
vaccine’s
To
eliminate
hesitancy,
in
HCPs,
certain
educational
strategies
should
be
implemented
address
HCPs.
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(8), P. 1365 - 1365
Published: Aug. 15, 2023
Vaccine
hesitancy
has
been
a
contentious
issue
even
before
the
pandemic.
The
COVID-19
crisis
further
amplified
vaccine
hesitancy,
with
worries
about
adverse
effects,
cultural
and
religious
beliefs,
misinformation
on
social
media.
In
dermatology,
patients
pre-existing
skin
conditions
may
have
specific
concerns
impact
of
their
health.
Factors
such
as
cutaneous
reactions,
potential
flares
underlying
conditions,
fears
psoriasis
worsening
post-vaccination
contribute
to
hesitancy.
Healthcare
professionals,
including
dermatologists,
play
crucial
role
in
addressing
by
providing
accurate
information,
concerns,
understanding
psychological
patients.
concept
fatigue
is
also
explored,
noting
challenges
sustaining
acceptance
over
time,
especially
regards
booster
vaccinations.
Overcoming
requires
trust-building,
effective
communication
strategies,
collaboration
between
healthcare
workers
non-healthcare
individuals
combat
misinformation.
By
recognizing
factors,
dermatologists
can
increase
improve
public
health
efforts.
Heliyon,
Journal Year:
2023,
Volume and Issue:
9(11), P. e22215 - e22215
Published: Nov. 1, 2023
Vaccine
booster
dose
(VBD)
provides
a
potential
therapeutic
alliance
in
preventing
breakthrough
infection
and
new
variant's
arrival
while
preserving
long-lasting
host
immunity.
This
study
aimed
to
analyze
COVID-19
VBD
willingness
identified
the
key
determinants
of
acceptance
among
general
people
Bangladesh.
survey-based
applied
quantitative
research
paradigm.
A
validated,
anonymous,
multi-item
questionnaire
was
adopted
through
theoretical
review
pertinent
literature
on
topic.
Data
were
collected
between
August
2022─October
2022,
sampling
done
randomly.
total
704
individuals
invited
via
face-to-face
interview
approach;
however,
13.8
%
them
declined
give
consent,
which
resulted
participation
607
respondents.
The
main
outcome
measure
willingness.
Binary
logistic
regression
analysis
conducted
rationalize
study's
objectives.
pooled
vaccine
rate
70.0
(95
confidence
Interval
[CI]:
67─73)
Bangladeshi
people.
An
binary
revealed
that,
out
14
factors,
"efficacy",
"repeated
immunity",
"communication",
"trust"
showed
highly
significant
positive
association
(adjusted
odds
ratio
[aOR
]
=
2.151
95
CI:
1.391─
3.508,
aOR
2.033
1.299─
3.181,
2.552
1.557─4.183
respectively,
p<0.01),
"equal
safety",
"risk-benefit
ratio"
"community
protection"
had
(aOR
1.739
1.070─2.825,
1.712
1.116─2.627,
1.628
1.395─0.998,
p<0.05)
with
acceptance.
However,
post-vaccination
"side
effects"
negative
0.393
0.237─0.674,
p<0.01)
associations
accepting
found
1.26,
it
insignificant
(p>0.05)
Chi-squared
test.
expressed
moderately
high
level
response
attitude
towards
is
an
this
study,
regardless
circumstances,
as
far
safety,
efficacy,
perceived
health
benefits,
communication,
trust,
community
resistance
are
concerned.
Post-vaccination
side
effects
fear
primary
reason
for
skepticism
well
barrier
administering
shots.
will
be
boosted
when
mass
effectively
communicated
vaccine's
data
become
more
available
publicly.
International Journal of Community Medicine and Public Health,
Journal Year:
2024,
Volume and Issue:
11(3), P. 1272 - 1276
Published: Feb. 29, 2024
Background:
Amidst
the
emerging
COVID-19
variants
worldwide,
India
started
COVID
precautionary
or
booster
dose
vaccination
by
early
2022.
Protecting
healthcare
force
is
crucial,
as
they
are
critical
drivers
in
increasing
vaccine
uptake
among
public.
Objective
was
to
assess
Booster
coverage
Health
Care
Workers
(HCWs)
and
know
reasons
for
hesitancy.
Methods:
A
cross-sectional
study
conducted
health
care
workers
Vijayapura
city,
during
April-May
The
questionnaire
google
form
shared
target
population,
wherever
necessary
phone
interview
done.
Data
tabulated
MS
office
Excel
analyzed
using
appropriate
statistical
tests.
Results:
Out
of
275
participants
from
different
levels
system,
50%
were
males,
75%
age
group
<40
years
67%
urban
area.
37%
took
against
COVID-19.
Among
those
who
did
not
take
a
shot,
22.5%
hesitant
were:
“Lack
faith
vaccination”,
“two
doses
sufficient”,
“Fear
side
effects”.
Socio
demographic
factors
such
age,
gender
residence
found
be
statistically
significant
with
status.
Conclusions:
Majority
aware
vaccination,
taking
mainly
lack
need
fear
effects.
Borneo Journal of Medical Sciences (BJMS),
Journal Year:
2024,
Volume and Issue:
18(3)
Published: Sept. 1, 2024
Vaccine
hesitancy
is
a
global
concern
and
significant
barrier
to
vaccine
uptake.
Healthcare
workers
(HCWs)
are
more
likely
contract
COVID-19
the
most
trusted
source
of
patient
vaccine-related
information.
This
scoping
review
summarized
rates
against
booster
dose
among
HCWs.
We
also
explored
determinants
acceptance.
The
method
was
described
according
PRISMA
extension
for
reviews.
Literature
search
from
PubMed,
Google
Scholar,
Scopus,
EBSCOhost
conducted
studies
published
January
2020
August
2022.
Themes
were
generated
using
inductive
deductive
methods
identify
acceptance
vaccine.
Overall,
total
157
articles
included
in
this
review.
rate
varied
before
vaccination
rollout
ranging
3.8%
79.0%,
while
1.1%-73.3%
after
rollout.
Six
themes
seven
vaccines.
identified
trust
issues
vaccines
or
authority;
vulnerability
infection
its
complications;
information
misinformation;
personal
past
experience;
religious
ethical;
socio-demographic
work
factors.
Professional
integrity
additional
theme
Safety
effectiveness
issues,
trust,
perceived
risk
infection,
misinformation
common
It
recommended
that
government
develops
strategies,
guidelines,
transparent
about
improve
vaccinations.
Vaccines,
Journal Year:
2022,
Volume and Issue:
10(10), P. 1736 - 1736
Published: Oct. 17, 2022
Background:
The
waning
vaccine
immunity
and
emergence
of
new
variants
SARS-CoV-2
led
health
authorities
across
the
globe
to
administer
booster
doses
(BDs)
COVID-19
vaccine.
Hence,
current
study
aimed
assess
hesitancy
(VBH)
amongst
Pakistani
healthcare
professionals
(HCPs).
Methods:
A
nationwide
survey-based
was
carried
out
from
April
2022
May
2022.
online
self-administered
questionnaire
utilized
collect
data
regarding
demographics
(age,
gender,
marital
status,
profession,
residential
area,
province),
infection
history
(infection
history,
onset,
clinical
severity
disease),
previous
vaccination
(type
number
doses),
attitudes
towards
BDs
(acceptance,
rejection,
hesitancy),
psychological
drivers
VBH
(perceived
effectiveness,
safety,
risk/benefit
ratio,
type
preference).
We
assessed
association
between
dependent
variable
participants,
independent
variables
(demographics,
vaccination,
VBH),
by
using
Chi-square
test/Fisher
exact
test.
Results:
Among
1164
51.4%
were
male,
80.4%
medical
professionals.
half
participants
(52.1%)
agreed
take
BD
or
had
already
taken
it,
while
rest
them
refused
(34.7%)
hesitated
(24.2%)
it.
These
significantly
associated
(p
<
0.001)
with
divers
about
BD.
Conclusion:
This
revealed
that
HCPs
hesitant
concerns
efficacy,
risk/benefits
ratio
vaccine’s
To
eliminate
hesitancy,
in
HCPs,
certain
educational
strategies
should
be
implemented
address
HCPs.
